Table 2.
Guideline recommended care vs. received care
| Recommended care | Met | Unmet | P |
|---|---|---|---|
| HbA1c < 8% (64 mmol/mol) when eGFR < 60 mL/min/1.73 m2 [7] | 68.1% (192/282) | 31.9% (90/282) | <0.00001 |
| Blood pressure < 140/90 mmHg [7, 8] | 60.7% (187/308) | 39.3% (121/308) | <0.00001 |
| A statin is recommended in patients with non-dialysis dependent CKD [7] | 82.3% (205/249) | 17.7% (44/249) | <0.00001 |
| In the setting of diabetic retinopathy, eye examinations should be repeated annually by an optometrist/ophthalmologist [20] | 87.8% (108/123) | 12.2% (15/123) | <0.00001 |
| In the setting of peripheral neuropathy feet should be examined every 3 months [20, 37] | 49.1% (53/108) | 50.9% (55/108) | 0.68 |
| Metformin should be ceased if eGFR ≤ 30 ml/min/m2 [7] | 96.2% (154/160) | 3.8% (6/160) | <0.00001 |
| ESAa prescribed if Hb < 100 g/L, allowing for individualisation [19] | 50.0% (11/22) | 50.0% (11/22) | 1.00 |
| Hb between 100 and 115 g/L while on ESA [19] | 31.3% (20/64) | 68.8% (44/64) | <0.00001 |
aESA = Erythropoietin Stimulating Agent